Terminated NA INTERVENTIONAL 1-arm NCT04912232

Trauma Study: Early Warning of Progression Toward Hemodynamic Deterioration After Trauma

Continued Development of a Multiplex Precision Medicine System for Early Warning of Progression Toward Hemodynamic Deterioration After Trauma

Sponsor: Baystate Medical Center

Conditions Hemorrhage Occult Bleeding

Interventions Detection of Occult Hemorrhage in Trauma Patients

Updated 5 times since 2021 Last updated: Apr 29, 2024 Started: Dec 8, 2022 Primary completion: Dec 8, 2022 Completion: Dec 8, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Grant funding for the study ended.

Other terminated trials from Baystate Medical Center

See all terminations from Baystate Medical Center

Listed as NCT04912232, this NA trial focuses on Hemorrhage and Occult Bleeding and remains terminated or withdrawn. Sponsored by Baystate Medical Center, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jun 2024 — Jul 2024 [monthly]

Terminated NA

Status: Not Yet Recruiting → Terminated · Phase: None → NA
Jan 2022 — Jun 2024 [monthly]

Not Yet Recruiting
Sep 2021 — Jan 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baystate Medical Center
Dartmouth College
Dartmouth-Hitchcock Medical Center
United States Department of Defense

Data source: Dartmouth-Hitchcock Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Springfield, United States